BRD4 is over-expressed in the inflamed mucosal areas of patients with CD and patients with UC [16], and its down-regulation with a specific antisense oligonucleotide (AS) in IBD LPMC reduces the synthesis of TNF-α, IL-17A, and IFN-γ [16]. The gene discussed is BRD4; the disease is inflammatory bowel disease.